EMORY UNIVERSITY Diversified Active

CIK: 0001377635 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $50,716 (100.0% shares, 0.0% debt)

Holdings (19)

BRK/A BERKSHIRE HATHAWAY INC DEL 61.5%

Value ($000) $31,183 Shares 100 Est. Cost $230816.08 Unrealized +34.1%

— EIDOS THERAPEUTICS INC 4.8%

Value ($000) $2,437 Shares 67,753 Est. Cost $31.08 Unrealized —

— SYNTHORX INC 4.7%

Value ($000) $2,362 Shares 145,150 Est. Cost $18.95 Unrealized —

WVE WAVE LIFE SCIENCES LTD 3.2%

Value ($000) $1,606 Shares 78,212 Est. Cost $32.02 Unrealized -28.4%

RYTM RHYTHM PHARMACEUTICALS INC 3.1%

Value ($000) $1,551 Shares 71,856 Est. Cost $27.45 Unrealized -21.8%

— RA PHARMACEUTICALS INC 2.8%

Value ($000) $1,412 Shares 59,690 Est. Cost $18.20 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS 2.7%

Value ($000) $1,375 Shares 479,902 Est. Cost $6.74 Unrealized -53.8%

MGTX MEIRAGTX HOLDINGS PLC 2.6%

Value ($000) $1,295 Shares 81,176 Est. Cost $20.65 Unrealized +12.7%

— ORCHARD THERAPEUTICS PLC 2.5%

Value ($000) $1,291 Shares 108,692 Est. Cost $17.88 Unrealized —

— ZOGENIX INC 2.0%

Value ($000) $997 Shares 24,890 Est. Cost $27.45 Unrealized —

ACA ARCOSA INC 1.9%

Value ($000) $955 Shares 27,923 Est. Cost $29.80 Unrealized +13.7%

HRTX HERON THERAPEUTICS INC 1.8%

Value ($000) $925 Shares 49,974 Est. Cost $27.34 Unrealized -32.7%

— RETROPHIN INC 1.8%

Value ($000) $895 Shares 77,180 Est. Cost $26.95 Unrealized —

— MYOVANT SCIENCES LTD 1.5%

Value ($000) $762 Shares 146,475 Est. Cost $12.79 Unrealized —

— GENOMIC HEALTH INC 1.3%

Value ($000) $645 Shares 9,506 Est. Cost $39.55 Unrealized —

— SUMMIT MIDSTREAM PARTNERS LP 0.7%

Value ($000) $342 Shares 70,456 Est. Cost $25.15 Unrealized —

— COCRYSTAL PHARMA INC 0.6%

Value ($000) $312 Shares 152,916 Est. Cost $5.95 Unrealized —

SPY SPDR S&P 500 ETF TR 0.6%

Value ($000) $280 Shares 942 Est. Cost $267.76 Unrealized —

IFRX INFLARX NV 0.2%

Value ($000) $91 Shares 36,818 Est. Cost $27.20 Unrealized -89.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BRK/A	BERKSHIRE HATHAWAY INC DEL	100	$31,183	61.5%	$230816.08	+34.1%	CL A	084670108
—	EIDOS THERAPEUTICS INC	67,753	$2,437	4.8%	$31.08	—	COM	28249H104
—	SYNTHORX INC	145,150	$2,362	4.7%	$18.95	—	COM	87167A103
WVE	WAVE LIFE SCIENCES LTD	78,212	$1,606	3.2%	$32.02	-28.4%	SHS	Y95308105
RYTM	RHYTHM PHARMACEUTICALS INC	71,856	$1,551	3.1%	$27.45	-21.8%	COM	76243J105
—	RA PHARMACEUTICALS INC	59,690	$1,412	2.8%	$18.20	—	COM	74933V108
BCRX	BIOCRYST PHARMACEUTICALS	479,902	$1,375	2.7%	$6.74	-53.8%	COM	09058V103
MGTX	MEIRAGTX HOLDINGS PLC	81,176	$1,295	2.6%	$20.65	+12.7%	COM	G59665102
—	ORCHARD THERAPEUTICS PLC	108,692	$1,291	2.5%	$17.88	—	ADS	68570P101
—	ZOGENIX INC	24,890	$997	2.0%	$27.45	—	COM NEW	98978L204
ACA	ARCOSA INC	27,923	$955	1.9%	$29.80	+13.7%	COM	039653100
HRTX	HERON THERAPEUTICS INC	49,974	$925	1.8%	$27.34	-32.7%	COM	427746102
—	RETROPHIN INC	77,180	$895	1.8%	$26.95	—	COM	761299106
—	MYOVANT SCIENCES LTD	146,475	$762	1.5%	$12.79	—	COM	G637AM102
—	GENOMIC HEALTH INC	9,506	$645	1.3%	$39.55	—	COM	37244C101
—	SUMMIT MIDSTREAM PARTNERS LP	70,456	$342	0.7%	$25.15	—	COM UNIT LTD	866142102
—	COCRYSTAL PHARMA INC	152,916	$312	0.6%	$5.95	—	COM PAR	19188J300
SPY	SPDR S&P 500 ETF TR	942	$280	0.6%	$267.76	—	TR UNIT	78462F103
IFRX	INFLARX NV	36,818	$91	0.2%	$27.20	-89.3%	COM	N44821101